Raymond Malamet

423 total citations
10 papers, 325 citations indexed

About

Raymond Malamet is a scholar working on Rheumatology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Raymond Malamet has authored 10 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 2 papers in Surgery. Recurrent topics in Raymond Malamet's work include Systemic Sclerosis and Related Diseases (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). Raymond Malamet is often cited by papers focused on Systemic Sclerosis and Related Diseases (4 papers), Systemic Lupus Erythematosus Research (3 papers) and Sympathectomy and Hyperhidrosis Treatments (2 papers). Raymond Malamet collaborates with scholars based in United States and Germany. Raymond Malamet's co-authors include Robert A. Wise, Fredrick M. Wigley, Herbert S. B. Baraf, Jeffrey R. Curtis, Akgun Ince, Yusuf Yazıcı, Arthur Kavanaugh, Lichen Teng, Alfonse T. Masi and G W Comstock and has published in prestigious journals such as Annals of the New York Academy of Sciences, The American Journal of Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Raymond Malamet

9 papers receiving 302 citations

Peers

Raymond Malamet

RHEUM

PFM

HEMAT

IMMUN

MB

Walter R. Sundstrom United States

S. von Schmiedeberg Germany

Manal Mohamed Kamal Egypt

Amal Mohamad El‐Barbary Egypt

Joseph J. Moellman United States

Xiqiang Dang China

Minako Yoshida Japan

Jeffrey E. Poiley United States

Shiv K. Seth United States

Daisy Vedder Netherlands

Walter R. Sundstrom United States

Raymond Malamet

144 ×0.8

RHEUM

29 ×0.4

PFM

28 ×0.4

HEMAT

34 ×0.5

IMMUN

29 ×0.6

MB

Citations per year, relative to Raymond Malamet Raymond Malamet (= 1×) peers Walter R. Sundstrom

Countries citing papers authored by Raymond Malamet

Since Specialization

Citations

This map shows the geographic impact of Raymond Malamet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Malamet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Malamet more than expected).

Fields of papers citing papers by Raymond Malamet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Malamet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Malamet. The network helps show where Raymond Malamet may publish in the future.

Co-authorship network of co-authors of Raymond Malamet

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Malamet. A scholar is included among the top collaborators of Raymond Malamet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Malamet. Raymond Malamet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Terkeltaub, Robert, Raymond Malamet, P.K. Bos, et al.. (2017). THU0455 Renal safety of lesinurad: a pooled analysis of phase iii and extension studies. Annals of the Rheumatic Diseases. 76. 379–380. 3 indexed citations

2.

Malamet, Raymond, et al.. (2017). THU0444 Integrated safety of lesinurad, a novel uric acid reabsorption inhibitor for the treatment of gout. Annals of the Rheumatic Diseases. 76. 375–376. 1 indexed citations

3.

Malamet, Raymond, et al.. (2013). SAT0355 Real World Risk of Infusion Reactions with Pegloticase Treatment: Findings from Post-Approval us Safety Data. Annals of the Rheumatic Diseases. 72. A703–A704.

4.

Yazıcı, Yusuf, Jeffrey R. Curtis, Akgun Ince, et al.. (2011). Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study. Annals of the Rheumatic Diseases. 71(2). 198–205. 128 indexed citations

5.

Masi, Alfonse T., Robert T. Chatterton, Jean C. Aldag, & Raymond Malamet. (2002). Perspectives on the Relationship of Adrenal Steroids to Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 966(1). 1–12. 13 indexed citations

6.

Comstock, G W, Anne E. Burke, Sandra C. Hoffman, et al.. (1997). Serum concentrations of α tocopherol, β carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 56(5). 323–325. 97 indexed citations

7.

Wigley, Fredrick M., et al.. (1987). Nicardipine in the treatment of raynaud's phenomenon. Arthritis & Rheumatism. 30(3). 281–286. 25 indexed citations

8.

Wise, Robert A., Raymond Malamet, & Fredrick M. Wigley. (1987). Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.. PubMed. 14(2). 278–83. 10 indexed citations

9.

Malamet, Raymond, Robert A. Wise, Walter H. Ettinger, & Fredrick M. Wigley. (1985). Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation. The American Journal of Medicine. 78(4). 602–608. 43 indexed citations

10.

Wise, Robert A., Fredrick M. Wigley, & Raymond Malamet. (1985). Digital Pressure-Flow Relationships in Subjects with Raynaud's Phenomenon. Angiology. 36(9). 596–602. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact